Jordan’s Health and Pharmaceutical Sector: A Royal Vision for Economy and Security
King Abdullah II’s meeting with the Jordanian American Physicians Association in New York on September 21, 2025, showed that health is more than a public service. It is a national priority linked to the economy and security. The King stressed the role of Jordanian doctors at home and abroad in building partnerships, supporting research, and raising Jordan’s competitiveness.
Health spending in Jordan reached about 9% of GDP in 2024. Per capita spending was around $430 a year, below the global average of $1,100, but higher than many nearby countries. These numbers reflect commitment, yet they also show the need to improve efficiency and deliver better results.
Health takes a big share of household spending compared to education and other needs. This highlights its importance for families but also shows the financial pressure of rising treatment and drug costs.
The pharmaceutical industry is a strong pillar of the economy. Jordan exports to more than 60 countries, and the sector makes up 8% of national exports. This success is built on quality and trust. The next step is to link the industry with research and innovation, and to attract investment in biotech and advanced medicine.
Digital tools can also transform the sector. Electronic records, telemedicine, and AI in diagnosis cut costs and improve efficiency.
Better medical education and continuous training will prepare skilled professionals. At the same time, foreign investment in medical technology and pharmaceuticals can expand opportunities.
Jordan is also a hub for medical tourism. Each year, more than 250,000 patients come from abroad, generating about $1.2 billion in revenues. This advantage can grow by creating integrated treatment packages that include accommodation, transport, and care. Another priority is a national “health map” to ensure fair distribution of services across provinces. Regional hospitals should have key specialties. Government field visits are a good start, but they must become part of regular work by local directorates, with performance measured by how well they solve local problems.
In a region full of instability, health is also a matter of security. Strong health and pharmaceutical systems are a first line of defense in times of crisis and a guarantee of resilience.
The King’s meeting in New York sets a new path. By using the skills of Jordanians abroad, building partnerships, and improving local systems, Jordan can turn health and pharmaceuticals into an investment in people, a driver of growth, and a pillar of national security.
King Abdullah II’s meeting with the Jordanian American Physicians Association in New York on September 21, 2025, showed that health is more than a public service. It is a national priority linked to the economy and security. The King stressed the role of Jordanian doctors at home and abroad in building partnerships, supporting research, and raising Jordan’s competitiveness.
Health spending in Jordan reached about 9% of GDP in 2024. Per capita spending was around $430 a year, below the global average of $1,100, but higher than many nearby countries. These numbers reflect commitment, yet they also show the need to improve efficiency and deliver better results.
Health takes a big share of household spending compared to education and other needs. This highlights its importance for families but also shows the financial pressure of rising treatment and drug costs.
The pharmaceutical industry is a strong pillar of the economy. Jordan exports to more than 60 countries, and the sector makes up 8% of national exports. This success is built on quality and trust. The next step is to link the industry with research and innovation, and to attract investment in biotech and advanced medicine.
Digital tools can also transform the sector. Electronic records, telemedicine, and AI in diagnosis cut costs and improve efficiency.
Better medical education and continuous training will prepare skilled professionals. At the same time, foreign investment in medical technology and pharmaceuticals can expand opportunities.
Jordan is also a hub for medical tourism. Each year, more than 250,000 patients come from abroad, generating about $1.2 billion in revenues. This advantage can grow by creating integrated treatment packages that include accommodation, transport, and care. Another priority is a national “health map” to ensure fair distribution of services across provinces. Regional hospitals should have key specialties. Government field visits are a good start, but they must become part of regular work by local directorates, with performance measured by how well they solve local problems.
In a region full of instability, health is also a matter of security. Strong health and pharmaceutical systems are a first line of defense in times of crisis and a guarantee of resilience.
The King’s meeting in New York sets a new path. By using the skills of Jordanians abroad, building partnerships, and improving local systems, Jordan can turn health and pharmaceuticals into an investment in people, a driver of growth, and a pillar of national security.
King Abdullah II’s meeting with the Jordanian American Physicians Association in New York on September 21, 2025, showed that health is more than a public service. It is a national priority linked to the economy and security. The King stressed the role of Jordanian doctors at home and abroad in building partnerships, supporting research, and raising Jordan’s competitiveness.
Health spending in Jordan reached about 9% of GDP in 2024. Per capita spending was around $430 a year, below the global average of $1,100, but higher than many nearby countries. These numbers reflect commitment, yet they also show the need to improve efficiency and deliver better results.
Health takes a big share of household spending compared to education and other needs. This highlights its importance for families but also shows the financial pressure of rising treatment and drug costs.
The pharmaceutical industry is a strong pillar of the economy. Jordan exports to more than 60 countries, and the sector makes up 8% of national exports. This success is built on quality and trust. The next step is to link the industry with research and innovation, and to attract investment in biotech and advanced medicine.
Digital tools can also transform the sector. Electronic records, telemedicine, and AI in diagnosis cut costs and improve efficiency.
Better medical education and continuous training will prepare skilled professionals. At the same time, foreign investment in medical technology and pharmaceuticals can expand opportunities.
Jordan is also a hub for medical tourism. Each year, more than 250,000 patients come from abroad, generating about $1.2 billion in revenues. This advantage can grow by creating integrated treatment packages that include accommodation, transport, and care. Another priority is a national “health map” to ensure fair distribution of services across provinces. Regional hospitals should have key specialties. Government field visits are a good start, but they must become part of regular work by local directorates, with performance measured by how well they solve local problems.
In a region full of instability, health is also a matter of security. Strong health and pharmaceutical systems are a first line of defense in times of crisis and a guarantee of resilience.
The King’s meeting in New York sets a new path. By using the skills of Jordanians abroad, building partnerships, and improving local systems, Jordan can turn health and pharmaceuticals into an investment in people, a driver of growth, and a pillar of national security.
comments
Jordan’s Health and Pharmaceutical Sector: A Royal Vision for Economy and Security
comments